Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX18,652.67+0.41%+76.73DAX18,652.670.41%
FTSE 1008,285.34+0.47%+38.39FTSE 1008,285.340.47%
CAC 408,040.12+0.42%+33.55CAC 408,040.120.42%
IBEX 3511,444.00+0.80%+90.90IBEX 3511,444.000.80%
STOXX 505,069.09+0.66%+33.43STOXX 505,069.090.66%

HomeSGMO • NASDAQ

Sangamo Therapeutics Inc

$0.59

After Hours:

$0.59

(0.00%)0.00

Closed: Jun 6, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Madrigal Pharmaceuticals Inc

$241.35

MDGL2.28%

Iovance Biotherapeutics Inc

$8.14

IOVA2.16%

Novavax Inc

$19.56

NVAX6.75%

Crispr Therapeutics AG

$59.96

CRSP0.40%

Amarin Corporation plc

$0.70

AMRN0.45%

Intellia Therapeutics Inc

$22.95

NTLA0.61%

Lexicon Pharmaceuticals Inc

$1.75

LXRX9.79%

Caribou Biosciences Inc

$2.09

CRBU1.65%

BioCryst Pharmaceuticals Inc

$6.44

BCRX5.15%

Editas Medicine Inc

$5.43

EDIT3.04%

In the news

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/9/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

481.00K-99.70%

Operating expense

Represents the total incurred expenses through normal operations

11.47M-36.77%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-49.09M-332.29%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-10.21K-76,375.11%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.25-153.01%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-44.87M-156.02%

Effective tax rate

The percent of their income that a corporation pays in taxes

-0.20%

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/9/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

54.42M-73.51%

Total assets

The total amount of assets owned by a company

128.96M-70.73%

Total liabilities

Sum of the combined debts a company owes

72.26M-31.15%

Total equity

The value of subtracting the total liabilities from the total assets of a company

56.70M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

207.51M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

2.09

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-78.63%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-110.97%

Net change in cash

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24. Reported on 5/9/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-49.09M-332.29%

Cash from operations

Net cash used or generated for core business activities

-48.66M26.60%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

35.84M0.31%

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

22.12M176.46%

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

8.63M138.86%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-27.47M-1,087.77%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on NASDAQ

US headquartered

Headquartered in Richmond, California, United States

Previous close

The last closing price

$0.59

Day range

The range between the high and low prices over the past day

$0.56 - $0.61

Year range

The range between the high and low prices over the past 52 weeks

$0.29 - $1.67

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

121.83M USD

Avg Volume

The average number of shares traded each day over the past 30 days

1.81M

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

NASDAQ

About

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. Wikipedia

CEO

Sandy Macrae

Founded

1995

Headquarters

Richmond, CaliforniaUnited States

Employees

405

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average38,886.170.20%
ISPIntesa Sanpaolo SpA€3.601.64%
AMZNAmazon.com Inc$185.002.05%
IndexEURO STOXX 505,069.090.66%
TSLATesla Inc$177.941.68%
IndexDAX PERFORMANCE-INDEX18,652.670.41%
IndexNasdaq-10019,021.190.073%
AAPLApple Inc$194.500.70%
UCGUniCredit SpA€36.502.54%
IndexNasdaq Composite17,173.120.086%
IndexVIX12.580.40%
IndexFTSE 100 Index8,285.340.47%
ENIEni SpA€14.070.89%
LDOLeonardo SpA€23.740.25%
ENELEnel S.p.A. Ordinary Shares€6.800.22%
GAssicurazioni Generali SpA€23.940.42%
IndexSTOXX Europe 600524.680.66%

People also search for

MDGLMadrigal Pharmaceuticals Inc$241.352.28%
IOVAIovance Biotherapeutics Inc$8.142.16%
NVAXNovavax Inc$19.566.75%
CRSPCrispr Therapeutics AG$59.960.40%
AMRNAmarin Corporation plc$0.700.45%
NTLAIntellia Therapeutics Inc$22.950.61%
LXRXLexicon Pharmaceuticals Inc$1.759.79%
CRBUCaribou Biosciences Inc$2.091.65%
BCRXBioCryst Pharmaceuticals Inc$6.445.15%
EDITEditas Medicine Inc$5.433.04%
BLUEbluebird bio Inc$0.913.48%
CLNNClene Inc.$0.356.04%
CTMXCytomX Therapeutics Inc$1.670.00%
TCRTAlaunos Therapeutics Inc$1.033.74%
BDTXBlack Diamond Therapeutics Inc$4.650.00%
RGTIRigetti Computing Inc$1.050.00%
PFEPfizer Inc$28.802.54%
RGNXRegenxbio Inc$13.765.23%

Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google Finance (2)HelpSend feedbackPrivacyTermsDisclaimer

Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google Finance (2024)

References

Top Articles
Latest Posts
Article information

Author: Fr. Dewey Fisher

Last Updated:

Views: 6364

Rating: 4.1 / 5 (62 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Fr. Dewey Fisher

Birthday: 1993-03-26

Address: 917 Hyun Views, Rogahnmouth, KY 91013-8827

Phone: +5938540192553

Job: Administration Developer

Hobby: Embroidery, Horseback riding, Juggling, Urban exploration, Skiing, Cycling, Handball

Introduction: My name is Fr. Dewey Fisher, I am a powerful, open, faithful, combative, spotless, faithful, fair person who loves writing and wants to share my knowledge and understanding with you.